FAQ

mTNF-PADRE

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2016
01219972016

Related topics

Related topics

1 relation

Broader (1)

Tumor Necrosis Factor-alpha

Related mentions per year

Related mentions per year

1954-2018
1960198020002020
mTNF-PADRE
Tumor Necrosis Factor-alpha

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
MtNF-YA1, A Central Transcriptional Regulator of Symbiotic Nodule Development, Is Also a Determinant of Medicago truncatula Susceptibility toward a Root Pathogen
Plant NF-Y transcription factors control a wide array of biological functions enabling appropriate reproductive and developmental… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms.
NGR-TNF is a vascular targeting agent in advanced clinical development, coupling tumor necrosis factor-α (TNF) with the CNGRCG… (More)
Is this relevant?
2014
2014
A rice-based soluble form of a murine TNF-specific llama variable domain of heavy-chain antibody suppresses collagen-induced arthritis in mice.
Tumor necrosis factor alpha (TNF) plays a pivotal role in chronic inflammatory diseases such as rheumatoid arthritis and Crohn's… (More)
Is this relevant?
2014
2014
Exploring Interaction of TNF and Orthopoxviral CrmB Protein by Surface Plasmon Resonance and Free Energy Calculation
Inhibition of the activity of the tumor necrosis factor (TNF) has become the main strategy for treating inflammatory diseases… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2010
2010
Mutant TNF-alpha, mTNF-K90R, is a novel candidate adjuvant for a mucosal vaccine against HIV.
The development of a safe and effective mucosal vaccine adjuvant is a crucial step for the development of vaccines against human… (More)
Is this relevant?
Review
2010
Review
2010
[Application of bioactive mutant TNF alpha to a mucosal vaccine adjuvant].
A large number of emerging pathogens, such as severe acute respiratory syndrome (SARS), human immunodeficiency virus (HIV), and… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2009
2009
The use of a mutant TNF-alpha as a vaccine adjuvant for the induction of mucosal immune responses.
Safe and potent adjuvants are required in order to establish effective mucosal vaccines. Cytokines are promising adjuvants… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1997
1997
Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor…
The correlation of persistent tumor necrosis factor-alpha (TNF-alpha) activation with disease progression in patients infected… (More)
Is this relevant?